Rubius Therapeutics, Inc.

WELLS FARGO & COMPANY/MN

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

314

Value ($000)

0

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	0	0.0%	314	12/31/2022
2022 Q3	11/14/2022	0	0.0%	306	9/30/2022
2022 Q2	8/12/2022	0	0.0%	278	6/30/2022
2022 Q1	5/16/2022	242	0.0%	43,893	3/31/2022
2021 Q4	2/14/2022	559	0.0%	57,781	12/31/2021
2021 Q3	11/15/2021	848	0.0%	47,481	9/30/2021
2021 Q2	8/16/2021	1,105	0.0%	45,274	6/30/2021
2021 Q1	5/13/2021	195	0.0%	7,369	3/31/2021
2020 Q4	2/9/2021	238	0.0%	31,397	12/31/2020
2020 Q3	11/5/2020	93	0.0%	18,503	9/30/2020
2020 Q2	8/13/2020	111	0.0%	18,560	6/30/2020
2020 Q1	5/14/2020	84	0.0%	19,029	3/31/2020
2019 Q4	2/14/2020	184	0.0%	19,352	12/31/2019